enVVeno Medical Corporation NVNO
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -32.23% | -28.58% | -11.72% | -8.28% | -2.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.06% | -27.42% | -15.34% | -13.54% | -1.94% |
| Operating Income | 27.06% | 27.42% | 15.34% | 13.54% | 1.94% |
| Income Before Tax | 29.20% | 31.84% | 11.78% | 10.76% | -3.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.20% | 31.84% | 11.78% | 10.76% | -3.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.20% | 31.84% | 11.78% | 10.76% | -3.42% |
| EBIT | 27.06% | 27.42% | 15.34% | 13.54% | 1.94% |
| EBITDA | 27.08% | 27.46% | 15.25% | 13.43% | 1.71% |
| EPS Basic | 37.65% | 40.35% | 24.48% | 25.60% | 18.98% |
| Normalized Basic EPS | 34.10% | 35.99% | 27.90% | 29.37% | 24.80% |
| EPS Diluted | 37.65% | 40.35% | 24.48% | 25.60% | 18.98% |
| Normalized Diluted EPS | 34.10% | 35.99% | 27.90% | 29.37% | 24.80% |
| Average Basic Shares Outstanding | 13.62% | 14.19% | 16.56% | 20.10% | 27.47% |
| Average Diluted Shares Outstanding | 13.62% | 14.19% | 16.56% | 20.10% | 27.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |